What is IP licensing in one line: permission to use, without transfer of ownership.
You keep the asset. The licensee gets defined rights for a defined period, and you get paid.
Which sounds like the easier option than selling, and often is not. A licence leaves you holding the maintenance fees, the reporting relationship, the audits, and the obligation to police everyone who is not a licensee. Those are real costs, and they run for as long as the agreement does.
What can be licensed
| Right | What a licence permits | Typical use |
|---|---|---|
| Patents | Making, using, selling the claimed invention | Technology transfer, manufacturing |
| Patent applications | Rights contingent on grant | Early-stage deals, priced for uncertainty |
| Trademarks | Use of the mark on goods or services | Franchising, merchandising, brand extension |
| Copyright | Reproduction, distribution, adaptation | Software, content, publishing |
| Designs | Use of the protected appearance | Product and packaging |
| Trade secrets / know-how | Access and use under confidentiality | Manufacturing processes |
| Plant variety rights | Propagation and sale | Agriculture |
Most real deals bundle several. A manufacturing licence commonly pairs a patent with the know-how needed to actually run the process, because the patent teaches what is claimed and not necessarily how to do it economically.
Bundling has a term consequence. Patent royalties must stop at expiry, but know-how and trade secret elements can legitimately continue — provided the agreement separates them properly.
The process, stage by stage
1. Establish what you have
Confirm ownership and chain of title. Every assignment from inventor to current owner must be recorded. A gap in the chain is the most common thing that stops a deal during diligence.
Confirm the rights are in force. Maintenance fees paid, term remaining calculated, no terminal disclaimer complications.
Identify the claims that matter. A licensee is buying freedom to do a specific thing. Which claim covers it?
2. Find who is already using it
This is the stage that determines whether licensing is possible at all.
A licensee with no current use has little reason to pay. The realistic prospects are companies already practising the invention, or about to.
| How to find them | What it gives |
|---|---|
| Product teardowns and technical documentation | Direct evidence of use |
| Competitor patent citations to yours | They read it and built nearby |
| Industry standards referencing the technique | Broad, essential use |
| Trade publications and conference material | Who is shipping what |
| Litigation records in the field | Who has been asserted against before |
Forward citations are the cheapest signal. Companies whose patents cite yours have engineers who read it. That is not infringement, but it is a strong indication of where the technology is being worked on.
3. Build the evidence
A claim chart is the standard work product. Each claim element in one column, the corresponding feature of the target's product in the other, with cited sources.
Its credibility rests on the evidence, not the argument. Public documentation, manuals, specifications and teardown photographs carry weight. Assertions do not.
See patent claim chart for how to build one.
4. Value it
Establish the range before the conversation, because the first number spoken anchors the negotiation.
Comparable licences are the primary reference. Then adjust for exclusivity, remaining term, and how easily the technology could be designed around.
Work out the base, not just the rate. A percentage means nothing without the revenue figure it applies to. See patent royalty rates for typical ranges and why the base usually matters more than the percentage.
5. Approach
Tone determines what happens next. An approach that reads as a threat triggers a validity challenge; one that reads as a commercial proposal opens a negotiation.
| Approach | Likely response |
|---|---|
| Business development framing | Technical evaluation, then negotiation |
| Formal demand letter | Legal review, possible IPR petition, possible declaratory judgment suit |
A demand letter can create jurisdiction against you. An accused infringer who receives one may file a declaratory judgment action in their own preferred forum, which is a poor start.
6. Negotiate and document
The terms that matter most are rarely the headline rate.
| Term | Why it decides the value |
|---|---|
| Royalty base | Often worth more than the rate itself |
| Exclusivity | Exclusive excludes you too |
| Minimum annual royalties | Stops a licensee shelving the technology |
| Field of use | Lets you license the same patent elsewhere |
| Territory | Rights are national |
| Term and step-downs | Royalties must end at patent expiry |
| Audit rights | A reported number you cannot verify is an estimate |
| Sublicensing | Whether permitted, and your share |
| Improvements | Who owns what the licensee develops |
| Termination | Breach, cure period, insolvency |
Field of use is the most underused term. A patent licensed exclusively for automotive applications can still be licensed separately for aerospace, which turns one asset into several revenue streams.
Worked example: a university licence
A materials patent held by a research institution, licensed to a manufacturer.
| Stage | Duration | What happened |
|---|---|---|
| Ownership and status confirmed | 2 weeks | Chain of title clean, two fees paid, 11 years remaining |
| Prospect identification | 6 weeks | Nine companies practising or adjacent; four shortlisted |
| Claim charts prepared | 4 weeks | Two targets with clear element-by-element mapping |
| Valuation | 2 weeks | Comparables in materials at 3–6%; base set at coated component |
| Approach | 3 weeks | Business development framing; two responded |
| Technical evaluation by licensee | 5 months | The longest stage, and entirely out of the licensor's control |
| Negotiation | 3 months | Base, exclusivity and minimums contested |
| Drafting and signature | 6 weeks | — |
| Total | ~14 months |
The terms agreed
| Term | Agreed |
|---|---|
| Scope | Exclusive, field limited to industrial coatings |
| Territory | US and EU |
| Rate | 4% of net sales of the coated component |
| Upfront | $75,000, credited against year one |
| Minimum annual | $60,000 from year two |
| Step-down | 2% in the final three years of patent life |
| Audit | Annual; licensor pays unless variance exceeds 5% |
| Improvements | Licensee owns its own; licensor gets a non-exclusive grant-back |
The field limitation was the licensor's best move. Exclusive in industrial coatings left medical and aerospace applications free to license separately.
The minimum annual royalty was the second. Without it, an exclusive licensee could have taken the rights and done nothing for eleven years.
Fourteen months is normal. Anyone budgeting six weeks for a licensing deal is budgeting for a deal that does not happen.
What licensing costs you
The fees do not stop. You still own the patent, so you still owe $2,150, $4,040 and $8,280 at 3.5, 7.5 and 11.5 years — $14,470 across a large entity patent's life.
| Ongoing burden | Falls on |
|---|---|
| Maintenance fees | You |
| Royalty reporting and audits | You (monitoring), licensee (reporting) |
| Enforcement against non-licensees | You |
| Validity defence if challenged | You |
| Renewal decisions | You |
Enforcement against third parties is the underestimated one. A non-exclusive licensee has no obligation to police the market. If competitors infringe without a licence, dealing with them remains your problem and your expense.
Which is why the royalty has to clear the costs before any of it is profit. A licence generating $30,000 a year against a third maintenance fee of $8,280 plus monitoring is thinner than it looks.
Licensing versus selling
| Licence | Sale | |
|---|---|---|
| Ownership | Retained | Transferred |
| Payment | Over time | Once |
| Upside | Yours | Buyer's |
| Maintenance fees | Yours | Buyer's |
| Enforcement burden | Yours | Buyer's |
| Administration | Ongoing | None after closing |
| Certainty | Low | High |
Most patents end up doing neither. Only 41.4% of US utility patents granted in 2014 reached full term — 58.6% were abandoned because owners judged the fee not worth paying. See the patent survival curve.
Selling before the window closes is the option most owners overlook. A patent sold before a maintenance fee deadline is worth something; the same patent a month after the grace period ends is worth nothing. See how to sell my patent.
Who licenses successfully
Licensing works consistently for a narrow set of parties, and understanding why explains why it disappoints most individual owners.
| Party | Why licensing works for them |
|---|---|
| Universities | Dedicated technology transfer offices, standing industry relationships, portfolios large enough that a few deals carry the rest |
| Large operating companies | Technology outside their core business, plus legal resources to run programmes |
| Standards participants | Essential patents that implementers must license to comply |
| Specialist licensing firms | Scale, and dedicated staff for outreach and enforcement |
| Individual inventors | Rarely — no network, no monitoring capacity, no enforcement budget |
The common factor is portfolio scale and dedicated staff. Licensing is a sustained activity, not a transaction. Someone has to find prospects, run negotiations, process reports, audit, and enforce against non-licensees, year after year.
A single patent held by one person has none of that infrastructure. Which is why individual owners who set out to license frequently end up selling instead — or, more often, letting the patent lapse.
That is not an argument against trying. It is an argument for being realistic about the time commitment before turning down a sale in favour of a licensing plan that needs resources you do not have.
Where licensing deals fail
Most licensing conversations end without an agreement, and the reasons repeat.
| Failure point | What happened | Preventable? |
|---|---|---|
| Chain of title gap | An inventor never assigned, or a corporate transfer was never recorded | Yes — check first |
| No evidence of use | The licensor could not show the target actually practises the claims | Yes — build the chart |
| Validity challenge | The approach triggered an IPR petition instead of a negotiation | Partly — framing matters |
| Design-around | The licensee engineered around the claims for less than the royalty | Sometimes |
| Base dispute | Parties agreed a rate but never the revenue it applies to | Yes — settle the base first |
| Licensee stalled | Technical evaluation ran indefinitely with no deadline | Yes — set milestones |
| Short remaining term | Not enough years left to justify the licensee's integration cost | No — but knowable early |
The design-around risk sets the ceiling on any royalty. A licensee will pay up to roughly what avoiding the patent would cost them. If the claims can be circumvented with a modest engineering change, the royalty cannot exceed that change, whatever comparables suggest.
Which is why claim scope matters more than claim count. A single broad claim covering the only commercially viable approach is worth more than forty narrow ones describing one implementation.
Set a decision deadline in the first conversation. Open-ended technical evaluation is the most common way a licensing discussion dies — not through refusal, but through indefinite postponement while the patent term runs down.
IP licensing: the checklist
- Confirm chain of title is recorded and complete. Gaps stop deals at diligence, and fixing them takes weeks you will not have.
- Confirm the rights are in force and calculate remaining term. A short window caps what any licence can be worth.
- Identify who already practises the invention. Forward citations, teardowns, standards documents, trade press.
- Build a claim chart mapping each element to a specific, sourced feature.
- Establish your valuation range before making contact. The first number spoken anchors everything after it.
- Define the royalty base before arguing about the rate. It is usually worth more.
- Approach commercially, not as a threat. A demand letter invites an IPR petition and can hand the other side their choice of forum.
- Limit the field of use so the same patent can be licensed again elsewhere.
- Insist on minimum annual royalties for anything exclusive, or a licensee can shelve the technology and pay you nothing.
- Confirm the royalty stream clears the maintenance fees before treating any of it as income — and compare the whole arrangement against simply selling.